Emerging and High Growth Companies

Bird&Be in its US$13-million Series A financing Bird&Be in its US$13-million Series A financing

Bird&Be
Key Contact
David Jamieson

Partner, Emerging and High Growth Companies, Toronto

Team
Daniel Tyberg

Associate, Emerging and High Growth Companies, Toronto

On September 22, 2026, Bird&Be announced that it raised US$13 million in a Series A financing co-led by BDC Capital’s Thrive Fund and BFG Partners, with participation from BAM Ventures, Founder Collective, Rejuvenation Ventures and HSR Ventures. Bird&Be plans on utilizing the financing towards product development and expanding the retail distribution of its reproductive health products.

Bird&Be is a Toronto-based reproductive health company that provides fertility and wellness supplements and at-home testing products for men and women. Its products support customers at different stages of their reproductive health journey, including conception, pregnancy and postpartum recovery.

Osler, Hoskin & Harcourt LLP advised Bird&Be with a team consisting of David Jamieson and Daniel Tyberg (Emerging and High Growth Companies).

Value
US$13 million
Date Announced
September 22, 2026
Lead Office
Toronto
Key Contact
David Jamieson

Partner, Emerging and High Growth Companies, Toronto

Team
Daniel Tyberg

Associate, Emerging and High Growth Companies, Toronto